• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过靶向深度测序、表达谱分析和单细胞数字图像分析对 RHOA 突变阳性和阴性血管免疫母细胞 T 细胞淋巴瘤进行全面分析。

A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.

机构信息

Department of Pathology, Stanford University, Stanford, CA 94305, USA.

Agilent Technologies, Santa Clara, CA 95051, USA.

出版信息

Int J Mol Med. 2020 Oct;46(4):1466-1476. doi: 10.3892/ijmm.2020.4686. Epub 2020 Jul 28.

DOI:10.3892/ijmm.2020.4686
PMID:32945366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7447311/
Abstract

Angioimmunoblastic T‑cell lymphoma (AITL) is a uniquely aggressive mature T‑cell neoplasm. In recent years, recurrent genetic mutations in ras homolog family member A (RHOA), tet methylcytosine dioxygenase 2 (TET2), DNA methyltransferase 3 alpha (DNMT3A) and isocitrate dehydrogenase [NADP(+)] 2 (IDH2) have been identified as associated with AITL. However, a deep molecular study assessing both DNA mutations and RNA expression profile combined with digital image analysis is lacking. The present study aimed to evaluate the significance of molecular and morphologic features by high resolution digital image analysis in several cases of AITL. To do so, a total of 18 separate tissues from 10 patients with AITL were collected and analyzed. The results identified recurrent mutations in RHOA, TET2, DNMT3A, and IDH2, and demonstrated increased DNA mutations in coding, promoter and CCCTC binding factor (CTCF) binding sites in RHOA mutated AITLs vs. RHOA non‑mutated cases, as well as increased overall survival in RHOA mutated patients. In addition, single cell computational digital image analysis morphologically characterized RHOA mutated AITL cells as distinct from cells from RHOA mutation negative patients. Computational analysis of single cell morphological parameters revealed that RHOA mutated cells have decreased eccentricity (more circular) compared with RHOA non‑mutated AITL cells. In conclusion, the results from the present study expand our understanding of AITL and demonstrate that there are specific cell biological and morphological manifestations of RHOA mutations in cases of AITL.

摘要

血管免疫母细胞性 T 细胞淋巴瘤(AITL)是一种独特侵袭性成熟 T 细胞肿瘤。近年来,ras 同源家族成员 A(RHOA)、tet 甲基胞嘧啶双加氧酶 2(TET2)、DNA 甲基转移酶 3α(DNMT3A)和异柠檬酸脱氢酶[NADP(+)]2(IDH2)的反复遗传突变被认为与 AITL 相关。然而,目前缺乏对 AITL 进行深度分子研究,评估 DNA 突变和 RNA 表达谱以及数字图像分析。本研究旨在通过高分辨率数字图像分析评估几种 AITL 病例的分子和形态特征的意义。为此,共收集并分析了 10 例 AITL 患者的 18 个单独组织。结果鉴定出 RHOA、TET2、DNMT3A 和 IDH2 的反复突变,并证明 RHOA 突变的 AITL 与 RHOA 非突变病例相比,在编码区、启动子和 CCCTC 结合因子(CTCF)结合位点的 DNA 突变增加,以及 RHOA 突变患者的总生存率增加。此外,单细胞计算数字图像分析从形态上对 RHOA 突变的 AITL 细胞进行了特征描述,使其与 RHOA 突变阴性患者的细胞区分开来。单细胞形态参数的计算分析表明,与 RHOA 非突变的 AITL 细胞相比,RHOA 突变细胞的偏心率(更圆)降低。总之,本研究结果扩展了我们对 AITL 的认识,并证明了在 AITL 病例中存在 RHOA 突变的特定细胞生物学和形态表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/4e5b4e132c2a/IJMM-46-04-1466-g09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/711f4d38fe9c/IJMM-46-04-1466-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/1c8cfd7da0c3/IJMM-46-04-1466-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/036afa7aa916/IJMM-46-04-1466-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/974194c242bb/IJMM-46-04-1466-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/0d07e61c954d/IJMM-46-04-1466-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/6b4d274045e6/IJMM-46-04-1466-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/4e5b4e132c2a/IJMM-46-04-1466-g09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/711f4d38fe9c/IJMM-46-04-1466-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/1c8cfd7da0c3/IJMM-46-04-1466-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/036afa7aa916/IJMM-46-04-1466-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/974194c242bb/IJMM-46-04-1466-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/0d07e61c954d/IJMM-46-04-1466-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/6b4d274045e6/IJMM-46-04-1466-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ae/7447311/4e5b4e132c2a/IJMM-46-04-1466-g09.jpg

相似文献

1
A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.通过靶向深度测序、表达谱分析和单细胞数字图像分析对 RHOA 突变阳性和阴性血管免疫母细胞 T 细胞淋巴瘤进行全面分析。
Int J Mol Med. 2020 Oct;46(4):1466-1476. doi: 10.3892/ijmm.2020.4686. Epub 2020 Jul 28.
2
Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL.血管免疫母细胞性 T 细胞淋巴瘤中 RHOA 突变的临床病理意义:一项荟萃分析:AITL 中的 RHOA 突变。
Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):431-438. doi: 10.1016/j.clml.2021.03.002. Epub 2021 Mar 19.
3
Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma.血管免疫母细胞性T细胞淋巴瘤基因突变的生物学及临床意义综述
Cancer Sci. 2018 Mar;109(3):490-496. doi: 10.1111/cas.13393. Epub 2017 Nov 27.
4
The pathological features of angioimmunoblastic T-cell lymphomas with IDH2 mutations.具有 IDH2 突变的血管免疫母细胞性 T 细胞淋巴瘤的病理学特征。
Mod Pathol. 2019 Jul;32(8):1123-1134. doi: 10.1038/s41379-019-0254-4. Epub 2019 Apr 5.
5
Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.携带RHOA p.Gly17Val突变的血管免疫母细胞性T细胞淋巴瘤具有典型的临床和病理特征。
Am J Surg Pathol. 2016 Mar;40(3):335-41. doi: 10.1097/PAS.0000000000000555.
6
Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.血管免疫母细胞性T细胞淋巴瘤:通过突变谱分析获得的新分子见解
Oncotarget. 2017 Mar 14;8(11):17763-17770. doi: 10.18632/oncotarget.14846.
7
Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections.使用福尔马林固定石蜡包埋切片对伴有或不伴有RHOA G17V突变的血管免疫母细胞性T细胞淋巴瘤进行临床病理分析。
Am J Surg Pathol. 2016 Aug;40(8):1041-50. doi: 10.1097/PAS.0000000000000651.
8
IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.异柠檬酸脱氢酶2(IDH2)R172位点突变定义了血管免疫母细胞性T细胞淋巴瘤患者的一个独特亚组。
Blood. 2015 Oct 8;126(15):1741-52. doi: 10.1182/blood-2015-05-644591. Epub 2015 Aug 12.
9
Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis.克隆性造血中两种不同淋巴样增殖的平行进化。
Histopathology. 2022 Apr;80(5):847-858. doi: 10.1111/his.14619. Epub 2022 Mar 1.
10
RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.血管免疫母细胞性 T 细胞淋巴瘤中 RHOA G17V 突变:细胞学分型评估的潜在生物标志物。
Exp Mol Pathol. 2019 Oct;110:104294. doi: 10.1016/j.yexmp.2019.104294. Epub 2019 Aug 5.

引用本文的文献

1
Common clonal origin of three distinct hematopoietic neoplasms in a single patient: B-cell lymphoma, T-cell lymphoma, and polycythemia vera.同一患者中三种不同造血肿瘤的共同克隆起源:B 细胞淋巴瘤、T 细胞淋巴瘤和真性红细胞增多症。
Cold Spring Harb Mol Case Stud. 2024 Jan 10;9(4). doi: 10.1101/mcs.a006313. Print 2023 Dec.
2
Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients.基因异常有助于病理诊断,且EBV阳性细胞密度影响中国血管免疫母细胞性T细胞淋巴瘤患者的生存。
Chin J Cancer Res. 2023 Oct 30;35(5):536-549. doi: 10.21147/j.issn.1000-9604.2023.05.10.
3

本文引用的文献

1
The mutational constraint spectrum quantified from variation in 141,456 humans.从 141456 名人类个体的变异中量化的突变约束谱。
Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27.
2
Mutations in Primary Marginal Zone Lymphomas of Ocular Adnexa are Associated with Unique Morphometric Phenotypes.眼附属器原发性边缘区淋巴瘤的突变与独特的形态计量学表型相关。
Curr Eye Res. 2020 Dec;45(12):1583-1589. doi: 10.1080/02713683.2020.1762228. Epub 2020 Jun 19.
3
EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma.
fusion in ALK positive large B-cell lymphoma: a case report and review of literature.
ALK阳性大B细胞淋巴瘤中的融合:一例病例报告及文献复习
Front Oncol. 2023 May 25;13:1174606. doi: 10.3389/fonc.2023.1174606. eCollection 2023.
4
Metabolic determinants of tumour initiation.肿瘤起始的代谢决定因素。
Nat Rev Endocrinol. 2023 Mar;19(3):134-150. doi: 10.1038/s41574-022-00773-5. Epub 2022 Nov 29.
5
G17V induces T follicular helper cell specification and involves angioimmunoblastic T-cell lymphoma via upregulating the expression of PON2 through an NF-κB-dependent mechanism.G17V 通过 NF-κB 依赖的机制上调 PON2 的表达诱导滤泡辅助性 T 细胞的特化,并涉及血管免疫母细胞性 T 细胞淋巴瘤。
Oncoimmunology. 2022 Oct 11;11(1):2134536. doi: 10.1080/2162402X.2022.2134536. eCollection 2022.
6
Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma.影响外周T细胞淋巴瘤近端T细胞受体信号通路中基因的突变
Cancers (Basel). 2022 Jul 29;14(15):3716. doi: 10.3390/cancers14153716.
7
Neoplasms of follicular helper T-cells: an insight into the pathobiology.滤泡辅助性T细胞肿瘤:对病理生物学的深入了解
Am J Blood Res. 2022 Jun 20;12(3):64-81. eCollection 2022.
8
Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial.西达本胺联合泼尼松、依托泊苷和沙利度胺治疗中国未治疗的血管免疫母细胞 T 细胞淋巴瘤的多中心 II 期临床试验。
Am J Hematol. 2022 May;97(5):623-629. doi: 10.1002/ajh.26499. Epub 2022 Mar 11.
9
Mutations in and Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders.和基因的突变在移植后淋巴细胞增殖性疾病中富集。
Front Oncol. 2022 Jan 17;11:790481. doi: 10.3389/fonc.2021.790481. eCollection 2021.
EBV 状态对年轻的血管免疫母细胞性 T 细胞淋巴瘤患者具有预后意义。
Cancer Med. 2020 Jan;9(2):678-688. doi: 10.1002/cam4.2742. Epub 2019 Dec 2.
4
Fundamental roles of chromatin loop extrusion in antibody class switching.染色质环挤出在抗体类别转换中的基本作用。
Nature. 2019 Nov;575(7782):385-389. doi: 10.1038/s41586-019-1723-0. Epub 2019 Oct 30.
5
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype.基于图的基因组比对和基因分型与 HISAT2 和 HISAT-genotype。
Nat Biotechnol. 2019 Aug;37(8):907-915. doi: 10.1038/s41587-019-0201-4. Epub 2019 Aug 2.
6
Indolent In Situ B-Cell Neoplasms With MYC Rearrangements Show Somatic Mutations in MYC and TNFRSF14 by Next-generation Sequencing.下一代测序显示伴有 MYC 重排的惰性原位 B 细胞肿瘤存在 MYC 和 TNFRSF14 的体细胞突变。
Am J Surg Pathol. 2019 Dec;43(12):1720-1725. doi: 10.1097/PAS.0000000000001338.
7
Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C.利用捕获 Hi-C 技术鉴定 B 细胞淋巴瘤中的反复出现的非编码突变。
Blood Adv. 2019 Jan 8;3(1):21-32. doi: 10.1182/bloodadvances.2018026419.
8
VarSome: the human genomic variant search engine.VarSome:人类基因组变异搜索引擎。
Bioinformatics. 2019 Jun 1;35(11):1978-1980. doi: 10.1093/bioinformatics/bty897.
9
HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing data.HGT-ID:一种使用下一代测序数据检测人类病毒插入位点的高效敏感工作流程。
BMC Bioinformatics. 2018 Jul 17;19(1):271. doi: 10.1186/s12859-018-2260-9.
10
RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice.RhoA G17V 足以诱导自身免疫,并促进小鼠 T 细胞淋巴瘤的发生。
Blood. 2018 Aug 30;132(9):935-947. doi: 10.1182/blood-2017-11-818617. Epub 2018 May 16.